ArticleDiscover oncology2025
Targeted therapy for Wilms tumor: a bibliometric study of worldwide scientific activity and collaborative networks.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bibliometric analysis of congenital diaphragmatic hernia research models: evolution and insights from the past three decades.Pediatric surgery international · 2026Review
- Global expert profiles, research hotspots, and journal networks in pediatric surgery: an AI-assisted bibliometric analysis.World journal of pediatric surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
background and purposeWilms tumor (WT), or nephroblastoma, is the most common abdominal solid tumor in children with a recurrence rate as high as 15%. Targeted therapy is an effective treatment choice for patients with WT. This study aimed to evaluate the global research activity and collaborative networks of WT targeted therapy through the bibliometric analysis.
methodsThe Web of Science Core Collection (WoSCC) database was used to search related studies on targeted therapy for WT published between 1945 and 2024. Subsequently, the VOSviewer, Graphpad, and Bibliometrix package in the R Studio were applied to conduct bibliometric and visualized analysis.
resultsA total of 1,604 publications were included in our analysis. The USA (n = 572) took the dominant position in the number of publications and Harvard University contributed most papers (n = 122). Sugiyama H and Oka Y demonstrated superior performance in this domain, with Sugiyama H leading in the number of publications (n = 59) and Oka Y leading in terms of co-citations (n = 382). The most productive journal was the Oncogene (n = 44). "Expression" and "Wilms Tumor" were the most frequent keywords, while "lncRNA", "Biomarkers" and "microRNA" were recent hotspots.
conclusionsResearch on targeted therapy for WT has developed rapidly with increasing interests, which emphasizes its growing importance in the scientific community. Nonetheless, the primary research has been primarily concentrated in a limited number of developed regions, and global collaboration remains inadequate. International collaborations and translational research should be reinforced to facilitate further advancements in this field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.